Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v19.i1.20
pages 47-60

Cancer Treatment-Related Bone Disease

Sue A. Brown
Department of Medicine, University of Virginia, Charlottesville, Virginia, USA
Theresa A. Guise
Division of Endocrinology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900

RESUMO

Bone health may be impaired in many patients being treated for cancer. Primary tumors that reside in or form metastases to bone can result in compromised skeletal integrity. It has also been increasingly recognized that patients undergoing therapies for treatment of cancer are at higher risk of bone loss. These include androgen-deprivation therapy for prostate cancer and aromatase inhibitor therapy for breast cancer, among others. Hypogonadism induced by many of these cancer treatments results in bone loss and increases the risk of osteoporosis and fractures. Progress has been made in identifying the role of oral and intravenous bisphosphonates to prevent bone loss in these patients. This review discusses bone loss associated with cancer treatments, with a focus on breast cancer, prostate cancer, and survivors of childhood malignancies.


Articles with similar content:

From Targets to Targeted Therapies in Hepatocellular Carcinoma
Forum on Immunopathological Diseases and Therapeutics, Vol.5, 2014, issue 3-4
Melchiorre Cervello, Antonella Cusimano, Maria Rita Emma, Antonina Azzolina, Giuseppa Augello, James A. McCubrey, Daniele Balasus
Treatment of Pediatric Overweight and Obesity: Assessing the Options
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 3
Nahid Ranjbar, Cheryl A. Hall, Ashley Kurien
Iron in Multiple Myeloma
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 5
Manuel Penichet, Alan Llichtenstein, Tracy R. Daniels-Wells, Kristina VanderWall
Nuclear Factor-κB Signaling: A Contributor in Leukemogenesis and a Target for Pharmacological Intervention in Human Acute Myelogenous Leukemia
Critical Reviews™ in Oncogenesis, Vol.15, 2009, issue 1-2
Astrid Marta Olsnes, Elisabeth Ersvar, Oystein Bruserud, Bjorn Tore Gjertsen, Hakon Reikvam
Risk-Reducing Mastectomy
Journal of Long-Term Effects of Medical Implants, Vol.16, 2006, issue 4
Brent C. Faulkner, Richard Edlich, Kathryne L. Winters, Kant Y. Lin